BioPlus continues Pay It Forward program in 2015
BioPlus Specialty Pharmacy on Thursday announced that its charitable “Pay It Forward” campaign will be continuing in 2015. Read More »
BioPlus Specialty Pharmacy on Thursday announced that its charitable “Pay It Forward” campaign will be continuing in 2015. Read More »
Amgen said on Wednesday that its Biologics License Application (BLA) for talimogene laherparepvec will be reviewed by the Oncologic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) and the Cellular, Tissue and Gene Therapies Advisory Committee. Read More »
Amgen’s Phase 3 study assessing the safety and effectiveness of biosimilar candidate ABP 501 versus Humira in patients with moderate to sever rheumatoid arthritis revealed positive results. Read More »